bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM
Rhea-AI Summary
bioMérieux (OTC:BMXXY) has launched GENE-UP® PRO HRM, the first DNA-based test for detecting heat-resistant molds at the molecular level. Developed in partnership with Ocean Spray Cranberries, this innovative solution reduces testing time from 15 days to just 72 hours, offering significant operational benefits for juice and concentrate manufacturers.
The new test provides validated equivalency to the CMMEF Ch22 Reference Method while delivering faster results, helping manufacturers reduce storage costs and protect brand reputation. When used alongside GENE-UP® PRO ACB, the solution offers comprehensive quality control for beverage spoilage concerns.
Positive
- Reduces testing time from 15 days to 72 hours, significantly improving operational efficiency
- Helps manufacturers reduce storage costs and inventory holding time
- Provides validated equivalency to industry standard reference method
- Can be implemented alongside existing GENE-UP® PRO ACB for comprehensive quality control
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, BMXXY gained 5.71%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
DNA-Based Heat Resistant Mold Test Delivers Deeper Diagnostics in a Fraction of the Time, On-Site Solution is Now Available for Implementation
Developed in partnership with historic brand Ocean Spray Cranberries, Inc., the game-changing testing innovation can accurately identify the presence of viable heat-resistant molds with validated equivalency to the CMMEF Ch22 Reference Method. GENE-UP® PRO HRM also provides a significantly shorter time-to-result, reducing the current Compendial Method 15-day result time down to only 72 hours.
The lengthy Compendial Method 15-day time-to-result forces juice and concentrate producers to decide between incurring costly storage fees until test results are received or forgoing the waiting period and risk shipping spoilage-prone products. The reduced time-to-result with GENE-UP® PRO HRM fuels improved operational efficiencies, minimizes manufacturer storage costs, and safeguards brand reputation among consumers.
"bioMérieux is a longstanding diagnostic partner of the beverage industry, and we're always up for the challenge of solving our customer's toughest spoilage problems," said Ben Pascal, global head of the xPRO™ Program at bioMérieux. "We embraced the opportunity to partner with Ocean Spray to create a custom microbiology quality control test that had broader implications for all juice and concentrate manufacturers."
While typically posing no public health or safety risk, in recent years heat-resistant molds have become a top quality concern and operational bottleneck for beverage and concentrate manufacturers. Unlike other yeast and mold test kits in the market, GENE-UP® PRO HRM is an innovative and complete testing solution that targets ascospore profiles to ultimately determine the presence of viable heat-resistant molds, resulting in the most comprehensive and reliable testing solution available today.
"Our loyal consumers have come to trust the high quality of our products and the integrity of our brand," notes Chris McNamara, Ocean Spray FSQA Senior Manager. "As the juice industry has evolved over the years, so has the risk profile for spoilage concerns. As a farmer-owned cooperative, innovation is in our DNA. Partnering with bioMérieux resulted in the development of a cutting-edge quality control solution with benefits not just for Ocean Spray but the industry at large."
GENE-UP® PRO HRM can be implemented alongside bioMérieux's GENE-UP® PRO ACB, a real-time PCR assay that detects and predicts spoilage due to Alicyclobacillus, causing off flavors and aromas in finished juice products. Together, the offering collectively speeds up and boosts confidence in the quality process across all major beverage spoilage concerns while also reducing costs and improving yield. Both GENE-UP® PRO HRM and GENE-UP® PRO ACB are a result of bioMérieux's xPRO™ Program, an innovation engine within bioMérieux that challenges the status quo to advance molecular diagnostics.
To learn more about how GENE-UP® PRO HRM, GENE-UP® PRO ACB, or bioMérieux's other game-changing xPRO™ solutions can unlock operational efficiencies and cost savings, please visit https://www.biomerieux.com/us/en/our-offer/industry-products/gene-up-pro-hrm.html.
ABOUT BIOMÉRIEUX
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2024, revenues reached
bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
www.biomerieux.com.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
CONTACTS
INVESTORS RELATIONS | ||
bioMérieux | ||
Aymeric Fichet | ||
Tel: +33 (0)4 78 87 20 00 | ||
MEDIA RELATIONS | ||
bioMérieux | bioMérieux | |
Romain Duchez | Maggie DiSantis | Samantha Flynn (JUNIPR) |
Tel: +33 (0)4 78 87 20 00 | Tel: (331) 385 1332 | Tel: (717) 413 0370 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomerieux-develops-game-changing-quality-control-solution-gene-up-pro-hrm-302522374.html
SOURCE bioMérieux
FAQ
What is bioMérieux's GENE-UP® PRO HRM and how does it work?
How much faster is GENE-UP® PRO HRM compared to traditional testing methods?
What benefits does GENE-UP® PRO HRM offer to juice manufacturers?
Can GENE-UP® PRO HRM be used with other bioMérieux testing solutions?
Who developed GENE-UP® PRO HRM and when was it launched?
